Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

APPENDIX 3B

3 May 2011 07:00

2 May 2011

We enclose an Appendix 3B detailing the expiration of the following unlisted Oilex Ltd Options:

350,000 options exercisable @ $2.70 expiry date 30 April 2011

For and on behalf of Oilex Ltd

Ben Clube

Finance Director / Company Secretary

cc: Directors - BMc/RB/MC/LLB/RM

Rule 2.7, 3.10.3, 3.10.4, 3.10.5 Appendix 3B New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/ 2001, 11/3/2002, 1/1/2003, 24/10/2005.

Name of entity OILEX LTD ABN 50 078 652 632

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

+Class of +securities issued or to be issued Number of +securities issued or to be issued (if known) or maximum number which may be issued Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion) Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities? If the additional securities do not rank equally, please state: * the date from which they do * the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment * the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment Issue price or consideration Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets) Dates of entering +securities into uncertificated holdings or despatch of certificates Number +Class Number and +class of all 253,274,885 Ordinary Shares +securities quoted on ASX (including the securities in clause 2 if applicable) Number +Class Number and +class of all 900,000 $1.75 Options due 30/06/2011 +securities not quoted on ASX (including the 900,000 $2.25 Options due 30/6/11 securities in clause 2 if applicable) 3,900,000 $2.00 Options due 1/07/2011 3,900,000 $2.50 Options due 01/07/2011 500,000 $1.57 Options due 30/09/2011 300,000 $2.75 Options due 31/3/2012 900,000 $2.75 Options due 30/06/2012 2,000,000 $0.30 Options due 15/09/2012 16,787,500 $0.30 Options due 10/11/2012 4,150,000 $0.30 Options due 01/07/2014 8,787,500 $0.37 Options due 10/11/2014 2006 Performance Rights 15,000 Tranche 1 expire 1/07/2011 2008 Performance Rights 21,000 Tranche 1 expire 1/07/2013 22,000 Tranch 2 expire 1/07/2013 22,000 Tranche 3 expire 1/07/2013 Dividend policy (in the N/A case of a trust, distribution policy) on the increased capital (interests)

Part 2 - Bonus issue or pro rata issue [Item 11 to 33 - Not Applicable]

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation ofsecurities34 Type of securities (tick one) (a) Securities described in Part 1 (b) All other securities Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a) [Items 35 to 42 - Not Applicable]

Additional securities forming a new class of securities

Quotation agreement

1. +Quotation of our additional +securities is in ASX's absolute discretion.

ASX may quote the +securities on any conditions it decides.

11. We warrant the following to ASX.

* The issue of the +securities to be quoted complies with the law and is not

for an illegal purpose.

* There is no reason why those +securities should not be granted +quotation.

* An offer of the +securities for sale within 12 months after their issue

will not require disclosure under section 707(3) or section 1012C(6) of the

Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

* Section 724 or section 1016E of the Corporations Act does not apply to any

applications received by us in relation to any +securities to be quoted and

that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted. * We warrant that if confirmation is required under section 1017F of the

Corporations Act in relation to the +securities to be quoted, it has been

provided at the time that we request that the +securities be quoted.

* If we are a trust, we warrant that no person has the right to return the

+securities to be quoted under section 1019B of the Corporations Act at the

time that we request that the +securities be quoted.

12. We will indemnify ASX to the fullest extent permitted by law in respect of

any claim, action or expense arising from or connected with any breach of

the warranties in this agreement.

13. We give ASX the information and documents required by this form. If any

information or document not available now, will give it to ASX before

+quotation of the +securities begins. We acknowledge that ASX is relying on

the information and documents. We warrant that they are (will be) true and

complete.

Sign here: .............................................. Date: 2 May 2011

(Finance Director / Company Secretary)

Print name: Ben Clube

vendor
Date   Source Headline
7th Aug 20209:32 amRNSTermination of JPDA Arbitration Proceedings
31st Jul 202011:07 amRNSJune 2020 Quarterly Report
31st Jul 202010:45 amRNSLoan Restructure and Equity Issue
30th Jul 20209:00 amRNSManaging Director Contract Extension
27th Jul 20207:00 amRNSWest Kampar Update
17th Jul 20207:07 amRNSIssue of Securities
30th Jun 202010:40 amRNSSuccessful Bid for Cooper Basin Permit
30th Jun 20208:17 amRNSResults of General Meeting
30th Jun 20208:11 amRNSExecutive Director Contract Extension
30th Jun 20208:05 amRNSChange of Registered Office
29th Jun 20207:00 amRNSIndia Update
15th Jun 202010:28 amRNSChange to Notice of Meeting
15th Jun 20207:56 amRNSArmour Share Purchase Agreement
5th Jun 202011:52 amRNSExtension to Armour Agreement
3rd Jun 20201:14 pmRNSNotice of Change of Interest of Substantial Holder
1st Jun 20207:15 amRNSExtension to Armour Agreement
29th May 20207:00 amRNSNotice of General Meeting
27th May 20209:28 amRNSSale of Cooper Eromanga Basin Assets
26th May 20207:00 amRNSNotice of Change of Interest of Substantial Holder
15th May 20207:00 amRNSIssue of Securities
6th May 20207:00 amRNSAppendix 3Z B Lingo
6th May 20207:00 amRNSReplacement Appendix 5B
5th May 20208:36 amRNSBoard Changes
30th Apr 20209:16 amRNSMarch 2020 Quarterly Report
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:35 pmRNSPrice Monitoring Extension
28th Apr 202011:02 amRNSCooper Basin Update
27th Apr 20207:14 amRNSCorrection: Variation to Financing Terms
23rd Apr 20201:45 pmRNSVariation to Financing Terms
3rd Apr 20207:00 amRNSChairman Consulting Contract Extension
3rd Apr 20207:00 amRNSExtension for Acquisition of Cooper Licences
26th Mar 20207:32 amRNSAppendix 3X Mark Bolton
26th Mar 20207:00 amRNSBoard and Executive Changes
24th Mar 20207:30 amRNSDoriemus Transaction - Update
16th Mar 20207:15 amRNSInterim Report 31 December 2019
16th Mar 20207:00 amRNSBusiness and Financial Restructure
12th Mar 20207:00 amRNSDoriemus Shareholders Approve Transaction
6th Mar 20207:15 amRNSOpportunity to Participate in Doriemus Offer
3rd Mar 202012:24 pmRNSUpdate on Cambay Sale Process
28th Feb 20209:29 amRNSExtension for Acquisition of Cooper Basin Licences
21st Feb 20207:30 amRNSStrong Funding Support for Cooper-Eromanga
11th Feb 20207:00 amRNSChairman Consulting Contract Extension
4th Feb 20207:00 amRNSAppendix 3B: Issue of Securities
3rd Feb 20202:23 pmRNSNew Series C Loan Facility
31st Jan 20208:17 amRNSDecember 2019 Quarterly Report
30th Jan 20207:00 amRNSDOR - Prop Acqn of Major Cooper-Eromanga Portfolio
29th Jan 202010:39 amRNSSale of Cooper Eromanga Basin Assets
28th Jan 20207:00 amRNSSale of Participating Interest in Bhandut
17th Jan 20202:05 pmRNSUpdate on Cambay Sale Process
7th Jan 20207:34 amRNSNotice of Change of Interest of Substantial Holder

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.